Compare IDEXX Laboratories, Inc. (IDXX) vs Direxion Daily 20 Year Treasury Bull 3X Shares (TMF) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
IDEXX Laboratories, Inc. vs Direxion Daily 20 Year Treasury Bull 3X Shares — how do they compare? IDEXX Laboratories, Inc. trades at $571.39 (market cap $46.22B), while Direxion Daily 20 Year Treasury Bull 3X Shares trades at $30.71. The key difference: IDEXX Laboratories, Inc. is trading nearer its 52-week high, Direxion Daily 20 Year Treasury Bull 3X Shares nearer its low. Which is the better fit depends on your goals.
| IDXX | TMF | |
|---|---|---|
Market Cap | $46.22B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $766.68 | $44.14 |
52-Week Low | $526.44 | $30.59 |
Enterprise Value | $47.12B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
IDEXX Laboratories (IDXX) trades at $571.44, down 4.08% over the past day, amid a mixed technical and strong fundamental backdrop. The stock shows a bullish trend in moving averages but overbought RSI readings near 73. Recent Q2 2026 earnings beat expectations with 9% organic revenue growth, and the company raised full-year EPS guidance. Profitability remains robust with a 25.03% net income margin and 74.21% ROE.
The outlook is positive given strong earnings momentum, high analyst buy ratings, and a consensus price target of $683.33 implying ~20% upside. Risks include premium valuation multiples and potential market volatility. The stock presents a growth opportunity supported by durable competitive advantages in veterinary diagnostics.
TMF, the Direxion Daily 20+ Year Treasury Bull 3X ETF, trades at $30.76, up 0.38% today, but technical indicators are predominantly bearish with moving averages signaling sell. Key financial ratios like P/E and P/S are unavailable, and the fund's leveraged structure amplifies volatility. Recent news highlights significant long-term losses, with a $10,000 investment five years ago now worth about $1,527, underscoring the risks of daily rebalancing.
The outlook for TMF is highly speculative, offering potential gains if long-term Treasury yields decline, but it carries extreme risk due to leverage decay and interest rate sensitivity. Investors should avoid long-term holdings, as the fund is suited only for short-term traders who can manage amplified losses. Macroeconomic shifts in bond markets remain the primary driver of performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →About Direxion Daily 20 Year Treasury Bull 3X Shares
TMF is a leveraged ETF that seeks to provide 300% (3x) of the daily performance of the ICE U.S. Treasury 20+ Year Bond Index. It is a tactical instrument used by sophisticated traders to capitalize on declining interest rates or to hedge against equity market volatility. Due to its daily reset mechanism and high expense ratio, TMF is structurally designed for short-term speculation rather than long-term buy-and-hold investing.
Read more on TMF →
